Study Results: Cerapedics’ i-FACTOR vs. Local Autologous Bone in ACDF
Published data show that i-FACTOR is not only cost-effective compared to autograft in ACDF, but is the dominant economic strategy. Aug 17, 2021
Smith+Nephew Launches WEREWOLF FASTSEAL 6.0 Hemostasis Wand
WEREWOLF FASTSEAL 6.0 brings radiofrequency technology to joint reconstruction surgeons. Aug 17, 2021
Royal Biologics Partners with Vilex for Lower Extremities
Vilex will market and distribute Royal Biologics' portfolio of Autologous and Live Cellular therapies for lower extremity orthopedic procedures. Aug 17, 2021
OssDsign Launches Catalyst Synthetic Bone Graft
OssDsign Catalyst is a synthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Aug 16, 2021
Limited Commercial Launch of SeaSpine WaveForm A
The 3D-printed implant is designed to balance geometric and manufacturing advancements without compromising clinical requirements. Aug 13, 2021
Exactech Fully Launches the Truliant Porous Knee
The implant is designed to mimic the trabecular nature of cancellous bone with optimal pore size and porosity. Aug 12, 2021
RSIP Vision Announces New Module for Orthopedic Surgery
The technology supports quantitative measurements of bones and implants to optimize implant positioning and improve patient outcomes. Aug 12, 2021
Next Science Begins Trial for XPERIENCE No Rinse Antimicrobial Solution
The randomized, controlled, double-blinded study will evaluate the effects of XPERIENCE solution in decreasing surgical site infections. Aug 12, 2021
Auctus Surgical: FDA Breakthrough Device Designation
The designation is a recognition that the Auctus dynamic vertebral body tethering system is unique and will meet a clear clinical need. Aug 11, 2021
WishBone Medical Receives $10 Million in Growth Capital
The funding will support product development and manufacturing to meet increasing market demand for pediatric orthopedic devices. Aug 10, 2021
